C-Peptide, Serum
Released in equal amounts to insulin when the pancreas produces it — but cleared more slowly, giving a stable picture of your own insulin production.
Distinguishes insulin your body made from insulin you injected, and measures true beta-cell function. Useful for separating type 1 from type 2 diabetes and assessing pancreatic reserve.
A C-peptide is uninterpretable without the glucose drawn at the same moment, and that single fact disposes of most 'optimal C-peptide' advice. A low C-peptide with a low glucose is appropriate physiology; the same low C-peptide with a high glucose is beta-cell failure. It also rises when the kidney clears it poorly, so a raised result in someone with reduced eGFR is not necessarily hyperinsulinemia. If the question is insulin resistance rather than insulin production, fasting insulin with glucose, run through HOMA-IR, is the better instrument — and it is one of the Vault's calculators.
Check a C-Peptide, Serum result against this range →
What C-Peptide, Serum actually measures — the analyte, and the assay
The analyte is the connecting peptide: the 31-amino-acid, roughly 3.0 kDa fragment excised from proinsulin when it is cleaved into insulin inside the beta-cell secretory granule. It leaves the cell in equimolar amounts with insulin, and that one-to-one relationship is the entire basis of the test.
Two pieces of physiology make it the better-behaved of the pair. C-peptide is not extracted by the liver, so what reaches a peripheral vein is proportional to what the pancreas actually secreted rather than to what survived a first pass. And its half-life is roughly 20 to 30 minutes against insulin's 4 to 6, so it integrates over a longer window and a single fasting value is far more representative. The price is that it is cleared by the kidney, which becomes the confound.
Unlike insulin, C-peptide can be harmonized, and has been. An isotope-dilution LC-MS/MS reference method achieved precision of 1.0% to 2.2% with analytical recoveries of 99.6% to 101.0%, correlated with six commercial immunoassays at R² above 0.98, and recalibrating those immunoassays against it substantially improved their comparability Deng 2023. The same effect appears in routine laboratories: across 94 of them, C-peptide's inter-method coefficient of variation fell from 24.5% to 5.7% after recalibration, while insulin's barely moved Zhou 2022. Antibody-free LC-MS/MS across three laboratories carried a median imprecision of 13.4% for C-peptide against 22.2% for insulin Moradian 2024.
The residual assay problem is proinsulin. C-peptide antibodies see intact proinsulin, which contains the C-peptide sequence, and in insulin autoimmune syndrome high-molecular-weight proinsulin has been shown to produce increased C-peptide immunoreactivity that is not increased C-peptide Kay 2021.
C-Peptide, Serum: what changes the blood, and what only changes the reading
What changes the C-peptide in your blood:
- Beta-cell secretion. The thing the test exists to measure. It rises with insulin resistance while the pancreas is compensating and falls as beta-cell mass is lost.
- The glucose concentration at the moment of the draw. C-peptide is a response, not a set point: a low value at a low glucose is appropriate and a low value at a high glucose is beta-cell failure. A C-peptide with no paired glucose is close to uninterpretable.
- Renal clearance. Because the kidney clears it and the liver does not, reduced glomerular filtration raises C-peptide without any extra secretion. In chronic kidney disease it is systematically high, which is the mirror image of the problem HbA1c has in the same patients.
- Secretagogues. Sulfonylureas and glinides raise it; GLP-1 receptor agonists raise stimulated secretion while usually lowering resting demand.
- Fasting duration and recent food, in the same direction and for the same reason as insulin, but damped by the longer half-life.
What changes only the reading:
- Proinsulin cross-reactivity, worst in the patients most likely to be tested Kay 2021.
- Insulin antibodies, which produce discordant insulin and C-peptide results and have been shown to interfere to different degrees across three immunoassays in one patient Teoli 2024; the full laboratory work-up for insulin autoimmune syndrome exists precisely because the raw numbers mislead Galván 2023.
- Sample handling. C-peptide degrades in whole blood left standing, and preanalytical loss on immunoassays is a documented and under-recognized error source Caruso 2020. Separate and freeze promptly, or accept a falsely low value.
- Which unit the laboratory used — see below, because this one changes clinical decisions.
Reference interval or decision threshold — which kind of number C-Peptide, Serum is
A reference interval for the fasting concentration, wrapped around a handful of genuine decision thresholds. A quoted 0.80–3.85 ng/mL fasting is the middle 95% of a measured population. The thresholds that matter clinically are different animals: values used to define severe endogenous insulin deficiency, and values used to argue against a diagnosis of type 1 diabetes, are cut-points chosen because they separate outcomes, not because they bound a population.
And they are almost always published in nmol/L while American reports print ng/mL. The conversion is 1 ng/mL = 0.331 nmol/L, so a threshold of 0.2 nmol/L is about 0.6 ng/mL and a threshold of 0.6 nmol/L is about 1.8 ng/mL. Reading a nmol/L cut-point against a ng/mL result understates your C-peptide by a factor of three. It is the most consequential unit trap in this cohort and it is on no report.
The interval is also assay-dependent in a way that is now measurable and improving: before recalibration the spread between commercial methods was around a quarter of the value, after it around a twentieth Zhou 2022 Deng 2023. That is the argument for asking whether your laboratory's method is traceable to the isotope-dilution reference procedure.
How you would know your C-Peptide, Serum was wrong — and when to redraw
The interval is set by what you are asking. Beta-cell mass changes over months to years, so for tracking pancreatic reserve, 6 to 12 months is right and anything shorter is noise. For classifying a confusing diabetes presentation, the useful measurement is not a fasting one at all — it is a random C-peptide with a simultaneous glucose, or a stimulated value, because a fasting C-peptide in someone whose glucose is 60 mg/dL is supposed to be low.
Conditions that must match: the same laboratory and method Deng 2023; a glucose drawn in the same tube, every time; stable kidney function, since falling filtration raises C-peptide on its own; the same fasting state; and prompt separation Caruso 2020.
What would have to change for the retest to mean something. The internal consistency check is insulin. Insulin and C-peptide are secreted equimolar, so on repeat they should move together once you allow for insulin's shorter half-life and hepatic extraction. If C-peptide fell and insulin did not, suspect the assay or an antibody Teoli 2024 Galván 2023. If C-peptide rose and eGFR fell, the kidney moved and the pancreas did not.
How you would know the value was wrong. A high C-peptide with recurrent documented hypoglycemia and no sulfonylurea is a formal diagnostic problem, and the differential includes both an insulinoma and high-molecular-weight proinsulin producing spurious immunoreactivity Kay 2021. A high insulin with an unremarkable C-peptide, in someone with access to insulin, is the classic signature of injected insulin — and detecting exactly that is the reason this test was put on the panel Teoli 2024.
What C-Peptide, Serum cannot tell you
It is uninterpretable without a simultaneous glucose. The single most common wrong use of this test is reading the number against a reference range with no idea what the pancreas was being asked to do at the moment of the draw.
It does not measure insulin resistance. A high C-peptide is consistent with a compensating pancreas in insulin resistance and also with reduced renal clearance, and the test cannot separate them without an eGFR.
It is not a substitute for insulin when the question is sensitivity, because the liver's first-pass extraction — the very thing C-peptide is immune to — is part of what determines the insulin concentration the rest of the body sees.
It cannot diagnose type 1 or type 2 on its own. It contributes to a classification that also needs autoantibodies, age, phenotype and course.
An immunoassay result is not proof of C-peptide. Proinsulin and antibody complexes both read as C-peptide, and the published cases in which they did were resolved by mass spectrometry, not by repeating the immunoassay Kay 2021 Galván 2023.
The wrong inference readers actually draw is that C-peptide is a better fasting insulin. It is a more stable and more standardizable measurement of secretion Zhou 2022 Rosli 2022, and secretion is not the same question as sensitivity. Run it when you need to know what the beta cells are doing, or whose insulin you are looking at.
Sources read for these sections
- Deng Y, et al. An Accurate Isotope Dilution Liquid Chromatography-Tandem Mass Spectrometry Method for Serum C-Peptide and Its Use in Harmonization in China. Annals of Laboratory Medicine 2023 · PMID 36843403
- Zhou W, et al. Current Status of Serum Insulin and C-Peptide Measurement in Clinical Laboratories: Experience from 94 Laboratories in China. Annals of Laboratory Medicine 2022 · PMID 35177563
- Moradian A, et al. Interlaboratory Comparison of Antibody-Free LC-MS/MS Measurements of C-peptide and Insulin. Clinical Chemistry 2024 · PMID 38549041
- Kay RG, et al. Increased C-Peptide Immunoreactivity in Insulin Autoimmune Syndrome (Hirata Disease) Due to High Molecular Weight Proinsulin. Clinical Chemistry 2021 · PMID 34051096
- Teoli J, et al. When discordant insulin and C-peptide levels lead to a medical diagnosis in a patient with transient hypoglycemia: Varying degrees of interference of insulin-antibody complexes on three insulin immunoassays. Heliyon 2024 · PMID 39071705
- Galván R, et al. Complete laboratory diagnosis of Insulin Autoimmune Syndrome. Practical Laboratory Medicine 2023 · PMID 37649545
- Rosli N, et al. Measurement comparability of insulin assays using conventional immunoassay kits. Journal of Clinical Laboratory Analysis 2022 · PMID 35622611
- Caruso B, et al. Causes of Preanalytical Interferences on Laboratory Immunoassays - A Critical Review. EJIFCC 2020 · PMID 32256291
Where to start with C-Peptide, Serum
In this order. Start at the supplement and you learn nothing, because you never established the number was real.
You have the range, where it came from and the first two moves. Inside is the rest of the five-pathway protocol — supplements, hormones, peptides — the order to run them in, and what to change when the number will not move.
Get the full protocol — $10/mo →📚 American Diabetes Association Standards of Care — C-peptide in diabetes classification.
🩸 Test your C-Peptide, Serum
Order directly through Marek Diagnostics — no doctor's visit needed, drawn at any Quest location in the US. Code CAMERON applies 10% off automatically.
Order this test — 10% off → Browse all 103 markers →What C-Peptide, Serum is usually tested alongside
One marker is a data point. These panels add the markers that make C-Peptide, Serum interpretable, name why each is on the list, and load the set into your cart at 10% off.
includes this + 8 more markers — Prediabetes, PCOS, stubborn central weight, a family history of diabetes, or a normal HbA1c you don't trust.
What people use C-Peptide, Serum to decide
Nobody orders a test for its own sake. C-Peptide, Serum is on the test list for these pathways — each one links to what the pathway claims, and what its test list is read for before you spend anything on it.
High fasting insulin with a normal glucose is the classic pre-diabetic picture, and it means appetite is being driven hormonally rather than by willpower. That is the strongest argument for this pathway. If insulin is genuinely low and you still can't stop eating, the driver is behavioral or psychological and no incretin will fix it.
Fasting insulin is the earliest signal and almost nobody orders it — glucose stays normal for years while insulin climbs to keep it there. Note that metformin depletes B12, which is why it is on this list.
The monitoring panel for anyone on a GLP-1. Lipase and amylase are there for the pancreatitis signal, and thyroid because of the medullary carcinoma contraindication — both are on the label and rarely tracked.
Why your C-Peptide, Serum might be wrong
Most abnormal results are interference, not disease. Check these before you change anything. Each says whether the number is wrong (repeat it), badly timed (redraw it), or real with a cause.
Rises after eating, so a non-fasted draw measures your breakfast rather than your baseline.
Draw fasted, 10–12 hours, water only.
C-peptide is the point of this test: injected insulin contains none, so a low C-peptide with a high insulin means the insulin came from outside the body. That is the intended use, not an artefact.
Note any insulin use — it changes the interpretation entirely.
C-peptide is cleared by the kidney, so impaired function raises it without any change in pancreatic output.
Read against eGFR, ideally cystatin C-based.
What C-Peptide, Serum means in combination
One marker tells you a little; combinations tell you the story. These are the named patterns this one takes part in.
C-peptide confirms the pancreas is still producing well, so this is a receptor-side problem rather than a production one. That distinction changes what actually helps.
Everything that improves insulin sensitivity applies and is likely to work: resistance training, fat loss, sleep, fiber, post-meal walking. A genuinely low C-peptide is the opposite situation and needs a clinician promptly.
What to test next
These put C-Peptide, Serum in context — each with its own full breakdown.
Frequently asked questions
0.80–3.85 ng/mL (fasting). Ranges vary by laboratory and assay — always compare to the range printed on your own report.
No established optimum - and no C-peptide is interpretable without the glucose drawn at the same moment. No guideline body publishes an optimal C-peptide concentration for healthy adults; diabetes guidance uses it categorically.
Confirms your pancreas is working overtime — the same story as high fasting insulin, but from a different angle.
Low C-peptide with high glucose means inadequate insulin production — a genuinely different clinical situation requiring medical management.
You can order C-Peptide, Serum directly through Marek Diagnostics without a doctor's visit — drawn at any Quest Diagnostics location in the US. Code CAMERON applies 10% off automatically.
Where this goes next
This page is the free framework. The protocol itself — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.